Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Anyone seeking visible results with minimal downtime
The trial randomized over 1,600 participants across the The ATTAIN Phase 3 global clinical development program for orforglipron has enrolled more than 4,500 people with obesity or overweight across two global registration trials
We are committed to providing the highest quality research materials
In the TRIUMPH-3 trial, adults with severe obesity and established cardiovascular disease, with or without type 2 diabetes, lost up to an average of 55.8 lbs (22.6%) at 80 weeks on the highest dose
Meister A: Glutathione
For type 2 diabetes, the Phase 1b data showed HbA1c reductions of up to 2.02% which, if confirmed in Phase 3, would make retatrutide competitive with the most effective diabetes medications available
US$ 20.72
US$ 25.46
US$ 23.59
US$ 24.57
US$ 25.21
US$ 22.49
